Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Nancy D. Campbell
Professor and Graduate Program Director, Science and Technology Studies (STS)Rensselaer Polytechnic Institute
Focuses on the history of science, technology, and medicine as it relates to drug policy and the social significance of drugs
John Brownstein
Chief Innovation OfficerBoston Children's Hospital
John Brownstein's research is focused on predicting patterns of epidemics and pandemics, and the efficacy of disease control strategies.
Liang Mao
Associate ProfessorUniversity of Florida
Liang Mao's research aims to offer better understandings on the human-disease system with geospatial science approaches and technologies.
Paul Meade
PresidentThought Leader Select
Innovative leader in healthcare, promoting thought leadership in medicine
Phil Tinmouth
Vice President & Head, Business Development & Alliance ManagementVertex Pharmaceuticals
Phil Tinmouth manages highly valuable and strategic collaborations in the biotechnology industry.
John McCulloch
Founder & Managing DirectorBurloch Group Inc.
Engaging and knowledgeable speaker with deep expertise in biotechnology investment.
Steve Demas
Director, Clinical Operations Study LeadershipBiogen
Steve Demas is an expert in the pharmaceutical industry specializing in clinical trials, pharmaceutics, oncology and clinical monitoring.
Rick Pierce
CEO and Co-founderSanaRx Biotherapeutics
Rick Pierce is a senior level executive and advisor, with expertise in attracting capital, forging transformative strategic alliances .
Robert Kemp
VP of Market Access and HEORBreath Therapeutics
Robert Kemp is an expert at developing value strategies using clinical and economic information.
Scott Requadt
CEOTalaris Therapeutics
Scott Requadt has operating and investment experience in the biopharmaceutical industry including therapeutics, medtech and diagnostics.